106 related articles for article (PubMed ID: 8635141)
21. Age-related prognostic factor analysis in non-Hodgkin's lymphoma.
Maksymiuk AW; Haines C; Tan LK; Skinnider LF
Can J Oncol; 1996 Jun; 6(1):435-42. PubMed ID: 8853516
[TBL] [Abstract][Full Text] [Related]
22. [Prognostic factors of primary non-Hodgkin's lymphoma of the nasal cavity--a report of 129 cases].
Yao B; Li YX; Fang H; Jin J; Liu XF; Yu ZH
Ai Zheng; 2006 Apr; 25(4):465-70. PubMed ID: 16613682
[TBL] [Abstract][Full Text] [Related]
23. Bcl-2 but not FOXP1, is an adverse risk factor in immunochemotherapy-treated non-germinal center diffuse large B-cell lymphomas.
Nyman H; Jerkeman M; Karjalainen-Lindsberg ML; Banham AH; Enblad G; Leppä S
Eur J Haematol; 2009 May; 82(5):364-72. PubMed ID: 19141121
[TBL] [Abstract][Full Text] [Related]
24. Prognostic indicators in diffuse, aggressive non-Hodgkin's lymphomas: regulators of growth fraction and programmed cell death.
Winter JN
Semin Oncol; 1999 Oct; 26(5 Suppl 14):26-33. PubMed ID: 10561015
[TBL] [Abstract][Full Text] [Related]
25. Low-grade non-Hodgkin's lymphoma in northern Norway: treatment, outcome, and prognostic factors.
Bremnes RM; Vik A; Helbekkmo N
Anticancer Res; 1998; 18(3B):1921-9. PubMed ID: 9677445
[TBL] [Abstract][Full Text] [Related]
26. Intestinal non-Hodgkin's lymphoma: a multicenter prospective clinical study from the German Study Group on Intestinal non-Hodgkin's Lymphoma.
Daum S; Ullrich R; Heise W; Dederke B; Foss HD; Stein H; Thiel E; Zeitz M; Riecken EO
J Clin Oncol; 2003 Jul; 21(14):2740-6. PubMed ID: 12860953
[TBL] [Abstract][Full Text] [Related]
27. [Detection of soluble interleukin-2 receptor in the serum of patients with non-Hodgkin's lymphoma].
Pérez Encinas M; Bello JL; Bendaña A; Rabuñal MJ; González S; Abuín I; Noya M; Cadarso C
Med Clin (Barc); 1998 Jul; 111(5):161-7. PubMed ID: 9732831
[TBL] [Abstract][Full Text] [Related]
28. DNA ploidy and cell kinetic characteristics in canine non-Hodgkin's lymphoma.
Teske E; Rutteman GR; Kuipers-Dijkshoorn NJ; van Dierendonck JH; van Heerde P; Cornelisse CJ
Exp Hematol; 1993 Apr; 21(4):579-84. PubMed ID: 8462667
[TBL] [Abstract][Full Text] [Related]
29. Reduced apoptotic cell death in follicular lymphoma.
Hollowood K; Macartney JC
J Pathol; 1991 Apr; 163(4):337-42. PubMed ID: 2033492
[TBL] [Abstract][Full Text] [Related]
30. [Treatment effect of DICE regimen on patients with relapsed or refractory intermediate and high grade non-Hodgkin's lymphoma].
Zhou SY; Shi YK; He XH; Zhang P; Dong M; Huang DZ; Yang JL; Zhang CG; Liu P; Yang S; Feng FY
Ai Zheng; 2005 Apr; 24(4):465-9. PubMed ID: 15820071
[TBL] [Abstract][Full Text] [Related]
31. Prolonged clinical and molecular remission in patients with low-grade or follicular non-Hodgkin's lymphoma treated with rituximab plus CHOP chemotherapy: 9-year follow-up.
Czuczman MS; Weaver R; Alkuzweny B; Berlfein J; Grillo-López AJ
J Clin Oncol; 2004 Dec; 22(23):4711-6. PubMed ID: 15483015
[TBL] [Abstract][Full Text] [Related]
32. Relevance of proliferative and pro-apoptotic factors in non-small-cell lung cancer for patient survival.
Volm M; Koomägi R
Br J Cancer; 2000 May; 82(10):1747-54. PubMed ID: 10817513
[TBL] [Abstract][Full Text] [Related]
33. Telomerase activity and expression of the telomerase catalytic subunit gene in non-small cell lung cancer: correlation with decreased apoptosis and clinical prognosis.
Wang J; Liu X; Jiang W; Liang L
Chin Med J (Engl); 2000 Nov; 113(11):985-90. PubMed ID: 11776132
[TBL] [Abstract][Full Text] [Related]
34. Hodgkin's and non-Hodgkin's lymphoma of the head and neck.
Urquhart A; Berg R
Laryngoscope; 2001 Sep; 111(9):1565-9. PubMed ID: 11568605
[TBL] [Abstract][Full Text] [Related]
35. Treatment results of tonsillar lymphoma: a 10-year experience.
Mohammadianpanah M; Omidvai S; Mosalei A; Ahmadloo N
Ann Hematol; 2005 Apr; 84(4):223-6. PubMed ID: 15042316
[TBL] [Abstract][Full Text] [Related]
36. A novel methionine aminopeptidase-2 inhibitor, PPI-2458, inhibits non-Hodgkin's lymphoma cell proliferation in vitro and in vivo.
Cooper AC; Karp RM; Clark EJ; Taghizadeh NR; Hoyt JG; Labenski MT; Murray MJ; Hannig G; Westlin WF; Thompson CD
Clin Cancer Res; 2006 Apr; 12(8):2583-90. PubMed ID: 16638869
[TBL] [Abstract][Full Text] [Related]
37. Centroblastic and centroblastic/centrocytic lymphoma associated with a prominent epithelioid granulomatous response: a clinicopathologic study of 50 cases.
Kojima M; Nakamura S; Ichimura K; Suzuki R; Kagami Y; Kondo E; Motoori T; Hosomura Y; Oyama T; Itoh H; Ban S; Yoshida K; Ohno Y; Shimizu K; Masawa N; Sugihara S
Mod Pathol; 2002 Jul; 15(7):750-8. PubMed ID: 12118113
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathologic characteristics and outcome of diffuse large B-cell lymphomas presenting with an associated low-grade component at diagnosis.
Ghesquières H; Berger F; Felman P; Callet-Bauchu E; Bryon PA; Traverse-Glehen A; Thieblemont C; Baseggio L; Michallet AS; Coiffier B; Salles G
J Clin Oncol; 2006 Nov; 24(33):5234-41. PubMed ID: 17043351
[TBL] [Abstract][Full Text] [Related]
39. Flow cytometric DNA analysis: a prognostic tool in non-Hodgkin's lymphoma.
Christensson B; Lindemalm C; Johansson B; Mellstedt H; Tribukait B; Biberfeld P
Leuk Res; 1989; 13(4):307-14. PubMed ID: 2716347
[TBL] [Abstract][Full Text] [Related]
40. Mitotic activity in non-Hodgkin's lymphoma. Relation to the Kiel classification and to prognosis.
Akerman M; Brandt L; Johnson A; Olsson H
Br J Cancer; 1987 Feb; 55(2):219-23. PubMed ID: 3814492
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]